5-1-1 C100-3 C 3 3 ~ C22-3 (yr) cirrhosis (yr) (%) (%) ~ -56 5.7 43 100 1 14 (35) -2 14 (35) --f f 63 4.1 14 71 3 12 (30) f + +
Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis
β Scribed by Mark L. Bassett; June W. Halliday; Lawrie W. Powell
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 593 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
The role of the measurement of hepatic iron in the diagnosis of genetic hemochromatosis was studied, with particular reference to the differentiation of early hemochromatosis from alcoholic siderosis and the critical hepatic iron concentration associated with fibrosis in hemochromatosis. Hepatic iron was measured in 30 homozygous relatives of 17 hemochromatosis probands, 8 heterozygous relatives, 5 1 patients with alcoholic liver disease and 40 control subjects. Hepatic iron concentrations were greatly increased in the majority of homozygous hemochromatosis subjects, and there was little overlap with the other groups. In the absence of alcoholism, fibrosis or cirrhosis in hemochromatosis was present only with hepatic iron concentrations above a threshold of approximately 400 pmoles per gm (22.3 mg per gm) dry weight. In some heterozygous hemochromatosis subjects and in some alcoholic patients, hepatic iron concentrations were in the range seen in young homozygous subjects. However, an age-related rise in hepatic iron was Seen only in hemochromatosis homozygotes, and calculation of an hepatic iron index (hepatic ironlage) resulted in a clear distinction between homozygotes and the other three groups. It is concluded: (a) that chemical measurement of hepatic iron concentration, when corrected for the age of the subject, reli- ably distinguishes early hemochromatosis from alcoholic siderosis, and (b), that there appears to be a threshold level of hepatic iron above which there is a high risk of fibrosis.
π SIMILAR VOLUMES
Recently, Summers, Halliday and Powell (1) studied 42 patients with unequivocal primary hemochromatosis and six patients with equivocal initial results who after prolonged follow-up behaved as homozygotes. The researchers compared these patients with 15 heterozygous cases. In all subjects in the fir
To assess the value of type I11 procollagen peptide (sPIIIP) as a marker of hepatic fibrosis, sera from 73 patients with alcohol-related liver disease and 30 patients with idiopathic hemochromatosis (IHC) were studied by a specific radioimmunoassay. sPIIIP was increased in 87% of 30 patients with ci
The therapeutic management of patients with idiopathic hemochromatosis (IH) implies the evaluation of excess hepatic iron. This work was undertaken to confirm the value of computed tomography for the assessment of liver iron overload in such patients and to evaluate this technique during the course